These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 17206838)

  • 1. Design and synthesis of an array of selective androgen receptor modulators.
    Trump RP; Blanc JB; Stewart EL; Brown PJ; Caivano M; Gray DW; Hoekstra WJ; Willson TM; Han B; Turnbull P
    J Comb Chem; 2007; 9(1):107-14. PubMed ID: 17206838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Discovery of a novel series of nonsteroidal androgen receptor modulators: 5- or 6-oxachrysen-2-ones.
    Zhao S; Shen Y; van Oeveren A; Marschke KB; Zhi L
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3431-5. PubMed ID: 18442912
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and biological evaluation of novel selective androgen receptor modulators (SARMs) Part III: Discovery of 4-(5-oxopyrrolidine-1-yl)benzonitrile derivative 2f as a clinical candidate.
    Aikawa K; Asano M; Ono K; Habuka N; Yano J; Wilson K; Fujita H; Kandori H; Hara T; Morimoto M; Santou T; Yamaoka M; Nakayama M; Hasuoka A
    Bioorg Med Chem; 2017 Jul; 25(13):3330-3349. PubMed ID: 28454849
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure-Based Approach To Identify 5-[4-Hydroxyphenyl]pyrrole-2-carbonitrile Derivatives as Potent and Tissue Selective Androgen Receptor Modulators.
    Unwalla R; Mousseau JJ; Fadeyi OO; Choi C; Parris K; Hu B; Kenney T; Chippari S; McNally C; Vishwanathan K; Kilbourne E; Thompson C; Nagpal S; Wrobel J; Yudt M; Morris CA; Powell D; Gilbert AM; Chekler ELP
    J Med Chem; 2017 Jul; 60(14):6451-6457. PubMed ID: 28696695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discovery of novel androgen receptor antagonists: a hybrid approach of pharmacophore-based and docking-based virtual screening.
    Liu J; Liu B; Guo G; Jing Y; Zhao G
    Anticancer Drugs; 2015 Aug; 26(7):747-53. PubMed ID: 25933245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Circumventing anti-androgen resistance by molecular design.
    McGinley PL; Koh JT
    J Am Chem Soc; 2007 Apr; 129(13):3822-3. PubMed ID: 17348658
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rational design and synthesis of 4-((1R,2R)-2-hydroxycyclohexyl)-2(trifluoromethyl)benzonitrile (PF-998425), a novel, nonsteroidal androgen receptor antagonist devoid of phototoxicity for dermatological indications.
    Li JJ; Iula DM; Nguyen MN; Hu LY; Dettling D; Johnson TR; Du DY; Shanmugasundaram V; Van Camp JA; Wang Z; Harter WG; Yue WS; Boys ML; Wade KJ; Drummond EM; Samas BM; Lefker BA; Hoge GS; Lovdahl MJ; Asbill J; Carroll M; Meade MA; Ciotti SM; Krieger-Burke T
    J Med Chem; 2008 Nov; 51(21):7010-4. PubMed ID: 18921992
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Functional activities of the A and B forms of the human androgen receptor in response to androgen receptor agonists and antagonists.
    Gao T; McPhaul MJ
    Mol Endocrinol; 1998 May; 12(5):654-63. PubMed ID: 9605928
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinguishing androgen receptor agonists and antagonists: distinct mechanisms of activation by medroxyprogesterone acetate and dihydrotestosterone.
    Kemppainen JA; Langley E; Wong CI; Bobseine K; Kelce WR; Wilson EM
    Mol Endocrinol; 1999 Mar; 13(3):440-54. PubMed ID: 10077001
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Linking ligand-induced alterations in androgen receptor structure to differential gene expression: a first step in the rational design of selective androgen receptor modulators.
    Kazmin D; Prytkova T; Cook CE; Wolfinger R; Chu TM; Beratan D; Norris JD; Chang CY; McDonnell DP
    Mol Endocrinol; 2006 Jun; 20(6):1201-17. PubMed ID: 16574741
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of an anabolic selective androgen receptor modulator that actively induces death of androgen-independent prostate cancer cells.
    Schmidt A; Meissner RS; Gentile MA; Chisamore MJ; Opas EE; Scafonas A; Cusick TE; Gambone C; Pennypacker B; Hodor P; Perkins JJ; Bai C; Ferraro D; Bettoun DJ; Wilkinson HA; Alves SE; Flores O; Ray WJ
    J Steroid Biochem Mol Biol; 2014 Sep; 143():29-39. PubMed ID: 24565564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of p-carborane-based nonsteroidal progesterone receptor antagonists.
    Fujii S; Nakano E; Yanagida N; Mori S; Masuno H; Kagechika H
    Bioorg Med Chem; 2014 Oct; 22(19):5329-37. PubMed ID: 25151087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis and preliminary investigations into novel 1,2,3-triazole-derived androgen receptor antagonists inspired by bicalutamide.
    Altimari JM; Niranjan B; Risbridger GP; Schweiker SS; Lohning AE; Henderson LC
    Bioorg Med Chem Lett; 2014 Nov; 24(21):4948-53. PubMed ID: 25301770
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biological properties of androgen receptor pure antagonist for treatment of castration-resistant prostate cancer: optimization from lead compound to CH5137291.
    Kawata H; Arai S; Nakagawa T; Ishikura N; Nishimoto A; Yoshino H; Shiraishi T; Tachibana K; Nakamura R; Sato H
    Prostate; 2011 Sep; 71(12):1344-56. PubMed ID: 21308717
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction mechanism exploration of R-bicalutamide/S-1 with WT/W741L AR using molecular dynamics simulations.
    Liu H; An X; Li S; Wang Y; Li J; Liu H
    Mol Biosyst; 2015 Dec; 11(12):3347-54. PubMed ID: 26442831
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of 4-benzyl-1-(2H)-phthalazinone derivatives as novel androgen receptor antagonists.
    Inoue K; Urushibara K; Kanai M; Yura K; Fujii S; Ishigami-Yuasa M; Hashimoto Y; Mori S; Kawachi E; Matsumura M; Hirano T; Kagechika H; Tanatani A
    Eur J Med Chem; 2015 Sep; 102():310-9. PubMed ID: 26295173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Design and synthesis of 4-[3,5-dioxo-11-oxa-4,9-diazatricyclo[5.3.1.0(2,6)]undec-4-yl]-2-trifluoromethyl-benzonitriles as androgen receptor antagonists.
    Xiao HY; Balog A; Attar RM; Fairfax D; Fleming LB; Holst CL; Martin GS; Rossiter LM; Chen J; Cvjic ME; Dell-John J; Geng J; Gottardis MM; Han WC; Nation A; Obermeier M; Rizzo CA; Schweizer L; Spires T; Shan W; Gavai A; Salvati ME; Vite G
    Bioorg Med Chem Lett; 2010 Aug; 20(15):4491-5. PubMed ID: 20584610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Voyages to the (un)known: adaptive design of bioactive compounds.
    Schneider G; Hartenfeller M; Reutlinger M; Tanrikulu Y; Proschak E; Schneider P
    Trends Biotechnol; 2009 Jan; 27(1):18-26. PubMed ID: 19004513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the development of selective androgen receptor modulators.
    Zhang X; Lanter JC; Sui Z
    Expert Opin Ther Pat; 2009 Sep; 19(9):1239-58. PubMed ID: 19505196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Discovery of an androgen receptor modulator pharmacophore based on 2-quinolinones.
    van Oeveren A; Pio BA; Tegley CM; Higuchi RI; Wu M; Jones TK; Marschke KB; Negro-Vilar A; Zhi L
    Bioorg Med Chem Lett; 2007 Mar; 17(6):1523-6. PubMed ID: 17257838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.